Arla Plast AB (ARPL.ST)
Borensberg, SE
Arla Plast AB, through its subsidiary Arla Plast s.r.o., specializes in the global manufacturing and distribution of extruded plastic sheets. Its market reach extends across Sweden, Germany, the Czech Republic, Poland, the broader European continent, and various international territories. The company's product line features transparent polycarbonate, integral to applications such as safety eyewear, vehicle windows, ice hockey rink enclosures, machine guarding, acoustic barriers, protective shields, and swimming pool covers. Additionally, opaque polycarbonate is provided for items like luggage, wall cladding, diverse packaging solutions, and vehicle components. Arla Plast also supplies multiwall polycarbonate sheets, frequently employed in the construction of greenhouses, verandas, pool coverings, skylights, and numerous other building-related projects. Established in 1969, this Swedish-based company maintains its headquarters in Borensberg.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.26% | -5.96% | -13.40% | -13.21% | -18.23% | -17.24% | -13.76% | +12.77% | -29.22% | -29.22% | -29.22% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-02 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+2.5% Q1'26: -17.0% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-9.9% Q1'26: -26.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+10.3% Q1'26: +4.2% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+7.9% ★ Q1'26: +6.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%+14.3% ★ Q1'26: +8.3% (vs Q1'25)
-
Share dilution Chemicals: +0.0%0.0% Q1'26: -0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.25× ★ Q1'26: 1.76× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
927.49M
est: 901.00M (+2.9%)
|
957.75M
est: 961.00M (-0.3%)
|
1.02B
est: 1.04B (-2.2%)
|
1.40B
est: 1.44B (-2.7%)
|
1.43B
est: 1.66B (-13.6%)
|
1.71B
1.71B – 1.71B
+3.1% YoY
|
| EBITDA |
124.72M
est: 113.99M (+9.4%)
|
88.68M
est: 121.58M (-27.1%)
|
133.80M
est: 131.32M (+1.9%)
|
166.30M
est: 160.09M (+3.9%)
|
113.80M
est: 184.79M (-38.4%)
|
190.59M
190.59M – 190.59M
+3.1% YoY
|
| EBIT |
86.53M
est: 77.38M (+11.8%)
|
46.64M
est: 82.53M (-43.5%)
|
88.60M
est: 89.14M (-0.6%)
|
119.10M
est: 113.16M (+5.3%)
|
113.80M
est: 130.62M (-12.9%)
|
134.72M
134.72M – 134.72M
+3.1% YoY
|
| Net Income |
68.11M
est: 84.34M (-19.2%)
|
34.40M
est: 35.67M (-3.5%)
|
66.90M
est: 77.00M (-13.1%)
|
97.90M
est: 90.61M (+8.0%)
|
88.30M
est: 87.67M (+0.7%)
|
92.08M
92.08M – 92.08M
+5.0% YoY
|
| SGA |
102.83M
est: 110.94M (-7.3%)
|
110.59M
est: 118.33M (-6.5%)
|
138.20M
est: 127.80M (+8.1%)
|
187.20M
est: 185.45M (+0.9%)
|
213.70M
est: 214.06M (-0.2%)
|
220.78M
220.78M – 220.78M
+3.1% YoY
|
| EPS |
3.41
est: 4.02 (-15.2%)
|
1.72
est: 1.70 (+1.2%)
|
3.29
est: 3.67 (-10.4%)
|
4.67
est: 4.32 (+8.1%)
|
4.21
est: 4.18 (+0.7%)
|
4.39
4.39 – 4.39
+5.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jon Christian Krichau | MD, President & Chief Executive Officer | 5M | male |
| Anna Russberg | Operations Director Sweden | — | female |
| Sören Fischer | Operations Director of Germany & Interim Operations Director of Spain | — | male |
| Tomas Jon | Operation Manager of CZECH Republic | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ARPL.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
